Evidence map›Paper›PMID 34810136›Full record

ReviewResearch in social & administrative pharmacy : RSAP2022

Pharmacy practice in emergency response during the COVID-19 pandemic: Lessons from Australia.

Daya Ram Parajuli, Saval Khanal, Kannikar Hannah Wechkunanukul, Saurav Ghimire, Arjun Poudel

Abstract readReview
In one paragraph

Review in Research in social & administrative pharmacy : RSAP, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Pharmaceutical services department strategies and patient perception to maintain healthcare services during COVID-19 crisis.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2022
    Article
  10. The impact of the COVID-19 pandemic on pharmacy personnel in primary care.Primary health care research & development · 2022
    Article
  11. Article
  12. Exploring pharmacists' understanding and experience of providing LGBTI healthcare.Exploratory research in clinical and social pharmacy · 2022
    Article
  13. A cross-sectional investigation of the impact of COVID-19 on community pharmacy.Exploratory research in clinical and social pharmacy · 2022
    Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Daya Ram ParajuliPublic Health Department, Torrens University Australia, Adelaide, Australia; Flinders Rural Health South Australia, College of Medicine and Public Health, Flinders University, Renmark, Australia. Electronic address: daya.parajuli@torrens.edu.au.
Saval KhanalDivision of Health Sciences, Warwick Medical School, The University of Warwick, Coventry, United Kingdom.
Kannikar Hannah WechkunanukulPublic Health Department, Torrens University Australia, Adelaide, Australia; College of Nursing and Health Sciences, Flinders University, Adelaide, Australia. Electronic address: hannah.wechkunanukul@torrens.edu.au.
Saurav GhimireDivision of Pharmacy, School of Medicine, University of Tasmania, Hobart, Australia.
Arjun PoudelSchool of Clinical Sciences, Queensland University of Technology, Queensland, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The purpose of this paper is to provide an overview of the pharmacy practice and initiatives taken by the Australian federal government to ensure the continued supply of essential medicines under the conditions of an emergency response plan for COVID-19. During the pandemic, Australian pharmacists have been working collaboratively with multidisciplinary teams at the frontline to manage the equitable and safe supply of medicines despite the unprecedented situation. Although these presented problems for small pharmacies, social distancing policies were implemented widely to maintain personal and environmental hygiene and reduce the number of face-to-face patient visits. In collaboration with various pharmaceutical stakeholders, the Australian government responded rapidly to ensure equitable and sufficient supply with continued access to therapeutic goods during the pandemic. Additionally, vital policies and practices have been implemented, including supplying regular medicines at government-subsidized prices, a maximum one-month supply of some prescription medicines and purchase limits on over-the-counter medicines (one unit per purchase), medication management reviews through telehealth, electronic and digital prescribing, home delivery of medicines to vulnerable people and those in home isolation and the provision of serious shortage medicine substitution rights to pharmacists. Pharmacists were encouraged to communicate and collaborate with other local pharmacies to ensure that essential pharmacy services met community needs (e.g., opening hours). However, there has been a shortage of some medicines due to supply chain disruption and increased demand due to the pandemic. Higher demand for flu vaccinations, increased work pressure in pharmacies, and severe frustration and anxiety in pharmacy customers were also reported. Vigilance is required to monitor foreseeable shortages of therapeutics goods, particularly in regional pharmacies. There is an opportunity for long-term change to retain certain rights and roles based on the competence shown by pharmacists in this challenging period, such as telephone medication reviews, telehealth for MedsCheck and Diabetes MedsCheck, digital prescription handling and therapeutic substitution.

Indexed as

Community Pharmacy ServicesCOVID-19PharmaciesPharmacyPrescription DrugsAustraliaHumansPandemicsPharmacistsProfessional RolePrescription DrugsAustraliaCOVID-19PharmacistPharmacy

Identifiers

PMID34810136
PMCPMC8404372

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.